The global Phage Therapy market size was valued at USD 33 million in 2022 and is forecast to a readjusted size of USD 97.9 million by 2029 with a CAGR of 16.8% during review period.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report is a detailed and comprehensive analysis for global Phage Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Phage Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Phage Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Phage Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Phage Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Phage Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Phage Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Phage Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Phage Therapy, with revenue, gross margin and global market share of Phage Therapy from 2018 to 2023.
Chapter 3, the Phage Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Phage Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Phage Therapy.
Chapter 13, to describe Phage Therapy research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Phage Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Phage Therapy by Type
1.3.1 Overview: Global Phage Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Phage Therapy Consumption Value Market Share by Type in 2022
1.3.3 DsDNA Bacteriophage
1.3.4 SsDNA Bacteriophage
1.3.5 SsRNA Bacteriophage
1.3.6 Others
1.4 Global Phage Therapy Market by Application
1.4.1 Overview: Global Phage Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Animal Health
1.4.3 Aquaculture
1.4.4 Agriculture
1.4.5 Food Industry
1.4.6 Human Health
1.4.7 Others
1.5 Global Phage Therapy Market Size & Forecast
1.6 Global Phage Therapy Market Size and Forecast by Region
1.6.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Phage Therapy Market Size by Region, (2018-2029)
1.6.3 North America Phage Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Phage Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Phage Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Phage Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Phage Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 NPO Microgen
2.1.1 NPO Microgen Details
2.1.2 NPO Microgen Major Business
2.1.3 NPO Microgen Phage Therapy Product and Solutions
2.1.4 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 NPO Microgen Recent Developments and Future Plans
2.2 Proteon Pharmaceuticals
2.2.1 Proteon Pharmaceuticals Details
2.2.2 Proteon Pharmaceuticals Major Business
2.2.3 Proteon Pharmaceuticals Phage Therapy Product and Solutions
2.2.4 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Proteon Pharmaceuticals Recent Developments and Future Plans
2.3 Phagelux
2.3.1 Phagelux Details
2.3.2 Phagelux Major Business
2.3.3 Phagelux Phage Therapy Product and Solutions
2.3.4 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Phagelux Recent Developments and Future Plans
2.4 Intralytix
2.4.1 Intralytix Details
2.4.2 Intralytix Major Business
2.4.3 Intralytix Phage Therapy Product and Solutions
2.4.4 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intralytix Recent Developments and Future Plans
2.5 Micreos
2.5.1 Micreos Details
2.5.2 Micreos Major Business
2.5.3 Micreos Phage Therapy Product and Solutions
2.5.4 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Micreos Recent Developments and Future Plans
2.6 Eliava BioPreparations
2.6.1 Eliava BioPreparations Details
2.6.2 Eliava BioPreparations Major Business
2.6.3 Eliava BioPreparations Phage Therapy Product and Solutions
2.6.4 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eliava BioPreparations Recent Developments and Future Plans
2.7 Locus Biosciences,Inc
2.7.1 Locus Biosciences,Inc Details
2.7.2 Locus Biosciences,Inc Major Business
2.7.3 Locus Biosciences,Inc Phage Therapy Product and Solutions
2.7.4 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Locus Biosciences,Inc Recent Developments and Future Plans
2.8 Pharmex Group,LLC
2.8.1 Pharmex Group,LLC Details
2.8.2 Pharmex Group,LLC Major Business
2.8.3 Pharmex Group,LLC Phage Therapy Product and Solutions
2.8.4 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pharmex Group,LLC Recent Developments and Future Plans
2.9 Pherecydes Pharma
2.9.1 Pherecydes Pharma Details
2.9.2 Pherecydes Pharma Major Business
2.9.3 Pherecydes Pharma Phage Therapy Product and Solutions
2.9.4 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pherecydes Pharma Recent Developments and Future Plans
2.10 APS Biocontrol Ltd. (APS)
2.10.1 APS Biocontrol Ltd. (APS) Details
2.10.2 APS Biocontrol Ltd. (APS) Major Business
2.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Product and Solutions
2.10.4 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 APS Biocontrol Ltd. (APS) Recent Developments and Future Plans
2.11 Qingdao Phagepharm Bio-tech
2.11.1 Qingdao Phagepharm Bio-tech Details
2.11.2 Qingdao Phagepharm Bio-tech Major Business
2.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Product and Solutions
2.11.4 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Qingdao Phagepharm Bio-tech Recent Developments and Future Plans
2.12 Fixed-Phage Limited
2.12.1 Fixed-Phage Limited Details
2.12.2 Fixed-Phage Limited Major Business
2.12.3 Fixed-Phage Limited Phage Therapy Product and Solutions
2.12.4 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Fixed-Phage Limited Recent Developments and Future Plans
2.13 Zeptometrix
2.13.1 Zeptometrix Details
2.13.2 Zeptometrix Major Business
2.13.3 Zeptometrix Phage Therapy Product and Solutions
2.13.4 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Zeptometrix Recent Developments and Future Plans
2.14 Phage International, Inc.
2.14.1 Phage International, Inc. Details
2.14.2 Phage International, Inc. Major Business
2.14.3 Phage International, Inc. Phage Therapy Product and Solutions
2.14.4 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Phage International, Inc. Recent Developments and Future Plans
2.15 MicroMir
2.15.1 MicroMir Details
2.15.2 MicroMir Major Business
2.15.3 MicroMir Phage Therapy Product and Solutions
2.15.4 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 MicroMir Recent Developments and Future Plans
2.16 iNtODEWORLD, Inc.
2.16.1 iNtODEWORLD, Inc. Details
2.16.2 iNtODEWORLD, Inc. Major Business
2.16.3 iNtODEWORLD, Inc. Phage Therapy Product and Solutions
2.16.4 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 iNtODEWORLD, Inc. Recent Developments and Future Plans
2.17 NEXTBIOTICS
2.17.1 NEXTBIOTICS Details
2.17.2 NEXTBIOTICS Major Business
2.17.3 NEXTBIOTICS Phage Therapy Product and Solutions
2.17.4 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 NEXTBIOTICS Recent Developments and Future Plans
2.18 Armata Pharmaceuticals, Inc.
2.18.1 Armata Pharmaceuticals, Inc. Details
2.18.2 Armata Pharmaceuticals, Inc. Major Business
2.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Product and Solutions
2.18.4 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
2.19 Innophage
2.19.1 Innophage Details
2.19.2 Innophage Major Business
2.19.3 Innophage Phage Therapy Product and Solutions
2.19.4 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Innophage Recent Developments and Future Plans
2.20 Adaptive Phage Therapeutics
2.20.1 Adaptive Phage Therapeutics Details
2.20.2 Adaptive Phage Therapeutics Major Business
2.20.3 Adaptive Phage Therapeutics Phage Therapy Product and Solutions
2.20.4 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Adaptive Phage Therapeutics Recent Developments and Future Plans
2.21 TechnoPhage
2.21.1 TechnoPhage Details
2.21.2 TechnoPhage Major Business
2.21.3 TechnoPhage Phage Therapy Product and Solutions
2.21.4 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 TechnoPhage Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Phage Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Phage Therapy by Company Revenue
3.2.2 Top 3 Phage Therapy Players Market Share in 2022
3.2.3 Top 6 Phage Therapy Players Market Share in 2022
3.3 Phage Therapy Market: Overall Company Footprint Analysis
3.3.1 Phage Therapy Market: Region Footprint
3.3.2 Phage Therapy Market: Company Product Type Footprint
3.3.3 Phage Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Phage Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Phage Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Phage Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Phage Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Phage Therapy Consumption Value by Type (2018-2029)
6.2 North America Phage Therapy Consumption Value by Application (2018-2029)
6.3 North America Phage Therapy Market Size by Country
6.3.1 North America Phage Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Phage Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Phage Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Phage Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Phage Therapy Consumption Value by Type (2018-2029)
7.2 Europe Phage Therapy Consumption Value by Application (2018-2029)
7.3 Europe Phage Therapy Market Size by Country
7.3.1 Europe Phage Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Phage Therapy Market Size and Forecast (2018-2029)
7.3.3 France Phage Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Phage Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Phage Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Phage Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Phage Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Phage Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Phage Therapy Market Size by Region
8.3.1 Asia-Pacific Phage Therapy Consumption Value by Region (2018-2029)
8.3.2 China Phage Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Phage Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Phage Therapy Market Size and Forecast (2018-2029)
8.3.5 India Phage Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Phage Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Phage Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Phage Therapy Consumption Value by Type (2018-2029)
9.2 South America Phage Therapy Consumption Value by Application (2018-2029)
9.3 South America Phage Therapy Market Size by Country
9.3.1 South America Phage Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Phage Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Phage Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Phage Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Phage Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Phage Therapy Market Size by Country
10.3.1 Middle East & Africa Phage Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Phage Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Phage Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Phage Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Phage Therapy Market Drivers
11.2 Phage Therapy Market Restraints
11.3 Phage Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Phage Therapy Industry Chain
12.2 Phage Therapy Upstream Analysis
12.3 Phage Therapy Midstream Analysis
12.4 Phage Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Phage Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Phage Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Phage Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Phage Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. NPO Microgen Company Information, Head Office, and Major Competitors
Table 6. NPO Microgen Major Business
Table 7. NPO Microgen Phage Therapy Product and Solutions
Table 8. NPO Microgen Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. NPO Microgen Recent Developments and Future Plans
Table 10. Proteon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 11. Proteon Pharmaceuticals Major Business
Table 12. Proteon Pharmaceuticals Phage Therapy Product and Solutions
Table 13. Proteon Pharmaceuticals Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Proteon Pharmaceuticals Recent Developments and Future Plans
Table 15. Phagelux Company Information, Head Office, and Major Competitors
Table 16. Phagelux Major Business
Table 17. Phagelux Phage Therapy Product and Solutions
Table 18. Phagelux Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Phagelux Recent Developments and Future Plans
Table 20. Intralytix Company Information, Head Office, and Major Competitors
Table 21. Intralytix Major Business
Table 22. Intralytix Phage Therapy Product and Solutions
Table 23. Intralytix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Intralytix Recent Developments and Future Plans
Table 25. Micreos Company Information, Head Office, and Major Competitors
Table 26. Micreos Major Business
Table 27. Micreos Phage Therapy Product and Solutions
Table 28. Micreos Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Micreos Recent Developments and Future Plans
Table 30. Eliava BioPreparations Company Information, Head Office, and Major Competitors
Table 31. Eliava BioPreparations Major Business
Table 32. Eliava BioPreparations Phage Therapy Product and Solutions
Table 33. Eliava BioPreparations Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eliava BioPreparations Recent Developments and Future Plans
Table 35. Locus Biosciences,Inc Company Information, Head Office, and Major Competitors
Table 36. Locus Biosciences,Inc Major Business
Table 37. Locus Biosciences,Inc Phage Therapy Product and Solutions
Table 38. Locus Biosciences,Inc Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Locus Biosciences,Inc Recent Developments and Future Plans
Table 40. Pharmex Group,LLC Company Information, Head Office, and Major Competitors
Table 41. Pharmex Group,LLC Major Business
Table 42. Pharmex Group,LLC Phage Therapy Product and Solutions
Table 43. Pharmex Group,LLC Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Pharmex Group,LLC Recent Developments and Future Plans
Table 45. Pherecydes Pharma Company Information, Head Office, and Major Competitors
Table 46. Pherecydes Pharma Major Business
Table 47. Pherecydes Pharma Phage Therapy Product and Solutions
Table 48. Pherecydes Pharma Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Pherecydes Pharma Recent Developments and Future Plans
Table 50. APS Biocontrol Ltd. (APS) Company Information, Head Office, and Major Competitors
Table 51. APS Biocontrol Ltd. (APS) Major Business
Table 52. APS Biocontrol Ltd. (APS) Phage Therapy Product and Solutions
Table 53. APS Biocontrol Ltd. (APS) Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. APS Biocontrol Ltd. (APS) Recent Developments and Future Plans
Table 55. Qingdao Phagepharm Bio-tech Company Information, Head Office, and Major Competitors
Table 56. Qingdao Phagepharm Bio-tech Major Business
Table 57. Qingdao Phagepharm Bio-tech Phage Therapy Product and Solutions
Table 58. Qingdao Phagepharm Bio-tech Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Qingdao Phagepharm Bio-tech Recent Developments and Future Plans
Table 60. Fixed-Phage Limited Company Information, Head Office, and Major Competitors
Table 61. Fixed-Phage Limited Major Business
Table 62. Fixed-Phage Limited Phage Therapy Product and Solutions
Table 63. Fixed-Phage Limited Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Fixed-Phage Limited Recent Developments and Future Plans
Table 65. Zeptometrix Company Information, Head Office, and Major Competitors
Table 66. Zeptometrix Major Business
Table 67. Zeptometrix Phage Therapy Product and Solutions
Table 68. Zeptometrix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Zeptometrix Recent Developments and Future Plans
Table 70. Phage International, Inc. Company Information, Head Office, and Major Competitors
Table 71. Phage International, Inc. Major Business
Table 72. Phage International, Inc. Phage Therapy Product and Solutions
Table 73. Phage International, Inc. Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Phage International, Inc. Recent Developments and Future Plans
Table 75. MicroMir Company Information, Head Office, and Major Competitors
Table 76. MicroMir Major Business
Table 77. MicroMir Phage Therapy Product and Solutions
Table 78. MicroMir Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. MicroMir Recent Developments and Future Plans
Table 80. iNtODEWORLD, Inc. Company Information, Head Office, and Major Competitors
Table 81. iNtODEWORLD, Inc. Major Business
Table 82. iNtODEWORLD, Inc. Phage Therapy Product and Solutions
Table 83. iNtODEWORLD, Inc. Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. iNtODEWORLD, Inc. Recent Developments and Future Plans
Table 85. NEXTBIOTICS Company Information, Head Office, and Major Competitors
Table 86. NEXTBIOTICS Major Business
Table 87. NEXTBIOTICS Phage Therapy Product and Solutions
Table 88. NEXTBIOTICS Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. NEXTBIOTICS Recent Developments and Future Plans
Table 90. Armata Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 91. Armata Pharmaceuticals, Inc. Major Business
Table 92. Armata Pharmaceuticals, Inc. Phage Therapy Product and Solutions
Table 93. Armata Pharmaceuticals, Inc. Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Armata Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 95. Innophage Company Information, Head Office, and Major Competitors
Table 96. Innophage Major Business
Table 97. Innophage Phage Therapy Product and Solutions
Table 98. Innophage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Innophage Recent Developments and Future Plans
Table 100. Adaptive Phage Therapeutics Company Information, Head Office, and Major Competitors
Table 101. Adaptive Phage Therapeutics Major Business
Table 102. Adaptive Phage Therapeutics Phage Therapy Product and Solutions
Table 103. Adaptive Phage Therapeutics Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Adaptive Phage Therapeutics Recent Developments and Future Plans
Table 105. TechnoPhage Company Information, Head Office, and Major Competitors
Table 106. TechnoPhage Major Business
Table 107. TechnoPhage Phage Therapy Product and Solutions
Table 108. TechnoPhage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. TechnoPhage Recent Developments and Future Plans
Table 110. Global Phage Therapy Revenue (USD Million) by Players (2018-2023)
Table 111. Global Phage Therapy Revenue Share by Players (2018-2023)
Table 112. Breakdown of Phage Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Phage Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Phage Therapy Players
Table 115. Phage Therapy Market: Company Product Type Footprint
Table 116. Phage Therapy Market: Company Product Application Footprint
Table 117. Phage Therapy New Market Entrants and Barriers to Market Entry
Table 118. Phage Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Phage Therapy Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Phage Therapy Consumption Value Share by Type (2018-2023)
Table 121. Global Phage Therapy Consumption Value Forecast by Type (2024-2029)
Table 122. Global Phage Therapy Consumption Value by Application (2018-2023)
Table 123. Global Phage Therapy Consumption Value Forecast by Application (2024-2029)
Table 124. North America Phage Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Phage Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Phage Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Phage Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Phage Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Phage Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Phage Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Phage Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Phage Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Phage Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Phage Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Phage Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Phage Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Phage Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Phage Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Phage Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Phage Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Phage Therapy Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Phage Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Phage Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Phage Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Phage Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Phage Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Phage Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Phage Therapy Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Phage Therapy Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Phage Therapy Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Phage Therapy Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Phage Therapy Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Phage Therapy Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Phage Therapy Raw Material
Table 155. Key Suppliers of Phage Therapy Raw Materials
List of Figures
Figure 1. Phage Therapy Picture
Figure 2. Global Phage Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Phage Therapy Consumption Value Market Share by Type in 2022
Figure 4. DsDNA Bacteriophage
Figure 5. SsDNA Bacteriophage
Figure 6. SsRNA Bacteriophage
Figure 7. Others
Figure 8. Global Phage Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Phage Therapy Consumption Value Market Share by Application in 2022
Figure 10. Animal Health Picture
Figure 11. Aquaculture Picture
Figure 12. Agriculture Picture
Figure 13. Food Industry Picture
Figure 14. Human Health Picture
Figure 15. Others Picture
Figure 16. Global Phage Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Phage Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Phage Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Phage Therapy Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Phage Therapy Consumption Value Market Share by Region in 2022
Figure 21. North America Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Phage Therapy Revenue Share by Players in 2022
Figure 27. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Phage Therapy Market Share in 2022
Figure 29. Global Top 6 Players Phage Therapy Market Share in 2022
Figure 30. Global Phage Therapy Consumption Value Share by Type (2018-2023)
Figure 31. Global Phage Therapy Market Share Forecast by Type (2024-2029)
Figure 32. Global Phage Therapy Consumption Value Share by Application (2018-2023)
Figure 33. Global Phage Therapy Market Share Forecast by Application (2024-2029)
Figure 34. North America Phage Therapy Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Phage Therapy Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Phage Therapy Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Phage Therapy Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Phage Therapy Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Phage Therapy Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 44. France Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Phage Therapy Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Phage Therapy Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Phage Therapy Consumption Value Market Share by Region (2018-2029)
Figure 51. China Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 54. India Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Phage Therapy Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Phage Therapy Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Phage Therapy Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Phage Therapy Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Phage Therapy Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Phage Therapy Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Phage Therapy Consumption Value (2018-2029) & (USD Million)
Figure 68. Phage Therapy Market Drivers
Figure 69. Phage Therapy Market Restraints
Figure 70. Phage Therapy Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Phage Therapy in 2022
Figure 73. Manufacturing Process Analysis of Phage Therapy
Figure 74. Phage Therapy Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
